CAS: 1262132-81-9; 2-(7-Hydroxy-5-Phenethyl-[1,2,4]Triazolo[1,5-A]Pyridine-8-Carboxamido)Acetic Acid

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10906888-B2
    优先权日:2016-07-14
    标 题:Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
    发明人:CASIMIRO-GARCIA AGUSTIN; STROHBACH JOSEPH WALTER; HEPWORTH DAVID; LOVERING FRANK ELDRIDGE; CHOI CHULHO; ALLAIS CHRISTOPHE PHILIPPE; WRIGHT STEPHEN WAYNE
    权利人:PFIZER
    摘要:Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-10308615-B2
    优先权日:2015-05-29
    标 题:Heterocyclic compounds as inhibitors of Vanin-1 enzyme
    发明人:CASIMIRO-GARCIA AGUSTIN; CONDON JEFFREY SCOTT; FLICK ANDREW CHRISTOPHER; GOPALSAMY ARIAMALA; KIRINCICH STEVEN J; MATHIAS JOHN PAUL; STROBACH JOSEPH WALTER; XIANG JASON SHAOYUN; XING LI HUANG; WANG XIAOLUN
    权利人:PFIZER
    摘要:Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-10316018-B2
    优先权日:2015-08-27
    标题 :Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
    发明人:LEE KATHERINE LIN; ALLAIS CHRISTOPHE PHILIPPE; DEHNHARDT CHRISTOPH MARTIN; GAVRIN LORI KRIM; HAN SEUNGIL; HEPWORTH DAVID; LEE ARTHUR; LOVERING FRANK ELDRIDGE; MATHIAS JOHN PAUL; OWEN DAFYDD RHYS; PAPAIOANNOU NIKOLAOS; SAIAH EDDINE; STROHBACH JOSEPH WALTER; TRZUPEK JOHN DAVID; WRIGHT STEPHEN WAYNE; ZAPF CHRISTOPH WOLFGANG
    权利人:PFIZER
    摘要:Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Markham A. Enarodustat: First Approval. Drugs. 2021 Jan;81(1):169-174. doi: 10.1007/s40265-020-01444-3. 26(4):679-693. doi: 10.1111/1744-9987.13820. Epub 2022 Mar 7.
    3: Fukui K, Tanaka T, Nangaku M. Enarodustat to treat anemia in chronic kidney disease. Drugs Today (Barc). 2021 Aug;57(8):491-497. doi: 10.1358/dot.2021.57.8.3304877. 97(5):934-950. doi: 10.1016/j.kint.2019.12.007. Epub 2019 Dec 25. 37(2):825-829. doi: 10.21873/invivo.13148.
    6: Chen J, Shou X, Xu Y, Jin L, Zhu C, Ye X, Mei Z, Chen P. A network meta- analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease. Aging (Albany NY). 2023 Mar 27;15(6):2237-2274. doi: 10.18632/aging.204611. Epub 2023 Mar 27.

    合成参考文献


    参考文献:10.1007/978-3-030-70897-9_18
    摘要:Hanna R, Rastogi A. Anemia Management in Peritoneal Dialysis. 2021. In: Applied Peritoneal Dialysis.
    参考文献:10.1007/s11560-023-00635-9
    参考文献:10.1007/978-3-031-11665-0_59
    摘要:Greenbaum LA. Anemia in Chronic Renal Disease. 2023. In: Pediatric Kidney Disease.
    参考文献:10.1007/978-3-030-62087-5_45
    摘要:Gupta N, Wish JB. Management of Anemia in Peritoneal Dialysis Patients. 2023. In: Nolph and Gokal's Textbook of Peritoneal Dialysis.
    参考文献:10.1007/978-3-031-42045-0_15
    摘要:Yildirim S, Yildirim T. Anemia and Disorders of Hemostasis in Chronic Kidney Disease. 2023. In: Management of Chronic Kidney Disease.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知